ZTS Stock Analysis

Analyzing Zoetis Inc (ZTS): An Educational Research Review

Welcome to this detailed stock research review of Zoetis Inc (ZTS). This article is presented as an educational guide by StockValueFinder.com to help investors understand how to evaluate a company using a disciplined, metric-driven approach. Rather than relying on intuition or market hype, we use a systematic screening process to determine if a company meets specific financial health and valuation benchmarks.

Zoetis Inc operates within the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry. As a leader in animal health, the company focuses on developing and selling medicines and vaccines for livestock and companion animals. In this review, we will break down the StockValueFinder score, analyze the company's capital efficiency, evaluate its debt obligations, and examine its current valuation.

Why the StockValueFinder Score Matters

The StockValueFinder system assigns a numerical score to stocks based on how many of our rigorous financial tests they pass. For Zoetis Inc (ZTS), the current score is 73%.

A score of 73% indicates that the company passes a significant majority of the fundamental health and valuation screens. In our system, a high score suggests that the company possesses strong fundamentals, though it does not guarantee future performance. The current rating for ZTS is "REVIEW." A "REVIEW" rating typically suggests that while the fundamentals may be strong, there are specific areas—such as technical trends or specific balance sheet metrics—that require closer inspection before a definitive conclusion can be reached.

By using a percentage-based score, investors can quickly compare the relative strength of different companies within the same sector. For example, a company with a 90% score has passed nearly every test, whereas a company with a 40% score has failed more than half of the fundamental requirements.

EPS Strength and Consistency

Earnings Per Share (EPS) is a critical metric because it tells us how much profit a company generates for each outstanding share of stock. Consistency in EPS is often more important than a single year of high growth; a company that grows its earnings steadily is generally viewed as more predictable and less risky than one with volatile swings.

For Zoetis Inc, the EPS test is marked as "Passed." While the specific historical EPS figures were not supplied in this data set, the system recorded a pass based on the company's internal earnings history.

To understand why this matters, consider an educational example: Company A has EPS growth of 5%, 6%, 4%, and 5% over four years. Company B has EPS growth of 20%, -10%, 15%, and -5%. Even though Company B had a 20% spike, Company A is often considered a higher-quality business because its consistency allows for more accurate future modeling. Zoetis Inc has passed this screen, indicating that its earnings trajectory meets our standards for stability.

ROIC and Capital Efficiency

Return on Invested Capital (ROIC) is perhaps the most important metric for determining if a company is actually creating value. ROIC measures how efficiently a company uses its capital (both debt and equity) to generate profit.

Zoetis Inc has an ROIC of 20.84%.

At StockValueFinder, we generally prefer an ROIC of 10% or higher. An ROIC of 20.84% is considered very strong, as it suggests the company is highly efficient at turning its investments into profit. When a company's ROIC is significantly higher than its cost of capital, it is creating "economic value."

To put this in perspective, imagine two different companies. Company X has an ROIC of 15%, meaning for every $100 it invests in its business, it generates $15 in profit. Company Y has an ROIC of 4%, meaning it only generates $4 for every $100 invested. Company X is far more efficient and is better positioned to grow without needing to constantly raise new, expensive capital. Because ZTS is well above the 10% threshold, it passed the ROIC test.

Interest Coverage and Financial Safety

Interest coverage is a solvency ratio that determines how easily a company can pay the interest expenses on its outstanding debt. It is calculated by dividing earnings before interest and taxes (EBIT) by the interest expense.

The system indicates that Zoetis Inc "Passed" the interest coverage test. StockValueFinder prefers an interest coverage ratio of 6 or higher. A high ratio means the company has a large "cushion" to pay its creditors even if earnings temporarily dip.

For example, if a company has an interest coverage ratio of 8x, it earns eight times more than it owes in annual interest payments. This is a healthy position. Conversely, a company with a 2x coverage ratio is in a much riskier position; a small drop in revenue could leave them unable to meet their interest obligations, potentially leading to bankruptcy or forced restructuring. By passing this test, ZTS demonstrates a level of financial safety regarding its immediate debt obligations.

Debt Payback and Balance Sheet Discipline

While interest coverage looks at the ability to pay *interest*, the debt payback metric looks at the ability to pay off the *entire principal* of the debt using annual cash flows. This is a measure of long-term balance sheet discipline.

Zoetis Inc has a debt payback period of 3.96 years.

StockValueFinder prefers a debt payback period of 3 years or less. Because 3.96 years is greater than the 3-year threshold, ZTS did not pass this specific test.

To understand this metric, imagine two businesses. Business A can pay off all its debts in 1.5 years using its current cash flow; it is virtually debt-free in a very short window. Business B would take 7 years to pay off its debts. Business A is much more attractive because it has less long-term financial baggage and is less vulnerable to rising interest rates. While 3.96 years is not an extreme number, it exceeds our strict discipline threshold, which is why the test was marked as failed.

P/E Ratio and Valuation Discipline

A company can be fundamentally great but still be a poor investment if you pay too much for it. The Price-to-Earnings (P/E) ratio helps us determine if the stock is priced reasonably relative to its earnings.

Zoetis Inc has a P/E ratio of 13.48.

For valuation discipline, StockValueFinder generally prefers a P/E of 15 or lower. A lower P/E suggests that you are paying less for every dollar of profit the company earns. Because 13.48 is below 15, ZTS passed the P/E valuation test.

Consider this example: If Stock A has a P/E of 8 and Stock B has a P/E of 40, you are paying five times more for the earnings of Stock B. Assuming both companies have similar growth rates and quality, Stock A is the more value-oriented choice. A P/E of 13.48 suggests that Zoetis is currently trading at a reasonable valuation relative to our benchmarks.

Moving Average Trend and Entry Timing

While the metrics above focus on "what" to buy (fundamentals), the moving average and entry signals focus on "when" to buy (timing). Fundamentals tell us if a company is healthy; trends tell us if the market is currently accepting that health.

The moving average signal for Zoetis Inc is "WEAK TREND." Additionally, the entry signal, limit buy idea, pullback zone, and risk stop levels are all listed as "N/A."

It is important to understand that a "WEAK TREND" is not a statement about the quality of the company, but rather a reflection of the stock's price movement. Trend analysis is used for timing discipline—to avoid buying a stock while it is in a steep decline. An "N/A" for entry signals simply means the system has not identified a specific, high-probability entry window based on current price action.

For example, an investor might find a company with a 90% StockValueFinder score, but if the trend is "WEAK," they might wait for the trend to turn positive before entering. This prevents "catching a falling knife," where an investor buys a great company but continues to lose money as the price drops further.

Overall Financial Strengths and Weaknesses

When we aggregate the data for Zoetis Inc, a clear picture of the company's financial profile emerges.

**Strengths:** - **Capital Efficiency:** With an ROIC of 20.84%, the company is exceptionally good at generating returns from its invested capital. - **Valuation:** A P/E of 13.48 indicates the stock is not overpriced according to our 15x threshold. - **Earnings and Safety:** The company passed the EPS strength test and the interest coverage test, suggesting stable earnings and the ability to handle its interest payments.

**Weaknesses:** - **Debt Duration:** The debt payback period of 3.96 years exceeds our preferred 3-year limit, indicating a slightly heavier debt load than our strictest standards allow. - **Price Momentum:** The "WEAK TREND" signal suggests that the stock is not currently experiencing strong upward price momentum.

Risks and Limitations

Every investment carries risk. For Zoetis Inc, the primary risks identified through these metrics are related to its balance sheet and market sentiment. While the company can cover its interest payments, the time required to fully eliminate its debt is longer than our ideal window. In a high-interest-rate environment, long-term debt can become a burden if it needs to be refinanced.

Furthermore, the "WEAK TREND" indicates that the market is not currently driving the price higher. This could be due to broader sector headwinds in the healthcare industry or specific challenges facing drug manufacturers.

Educational Conclusion

Analyzing Zoetis Inc (ZTS) provides a textbook example of how to balance fundamental strength against valuation and timing. ZTS is a company with high capital efficiency (ROIC) and a reasonable valuation (P/E), which is why it achieved a strong StockValueFinder score of 73%. However, the failure of the debt payback test and the presence of a weak price trend explain why the rating is "REVIEW" rather than a more aggressive signal.

For students of value investing, the lesson here is that no single metric tells the whole story. A great ROIC is wonderful, but it must be balanced against how much debt the company took on to achieve that return. A low P/E is attractive, but it must be paired with a positive trend to ensure the market isn't pricing in a hidden problem. By checking all these boxes—EPS, ROIC, Interest Coverage, Debt Payback, and P/E—investors can make decisions based on data rather than emotion.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.

Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings